| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 299 | 701 | 1.235 | 58.263 | 27.751 | 51.954 | 60.677 | 75.119 | 154.611 |
| Total Income - EUR | - | 299 | 701 | 1.235 | 58.263 | 27.751 | 52.191 | 60.699 | 75.151 | 154.848 |
| Total Expenses - EUR | - | 19 | 195 | 61 | 2.208 | 254 | 15.482 | 6.426 | 14.122 | 28.711 |
| Gross Profit/Loss - EUR | - | 280 | 506 | 1.174 | 56.055 | 27.498 | 36.709 | 54.273 | 61.029 | 126.137 |
| Net Profit/Loss - EUR | - | 271 | 485 | 1.137 | 54.307 | 26.665 | 35.143 | 52.853 | 60.235 | 121.491 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Bellegynecologie Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 143 | 0 | 0 | 0 | 0 | 114.677 | 109.401 | 103.455 | 97.294 |
| Current Assets | - | 319 | 4.519 | 5.533 | 60.912 | 86.110 | 36.364 | 12.909 | 76.103 | 69.458 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 5.548 | 5.565 | 5.548 | 5.517 |
| Receivables | - | 0 | 3.551 | 95 | 18.548 | 5.592 | 295 | 5.308 | 1.518 | 62.693 |
| Cash | - | 319 | 968 | 5.439 | 42.363 | 80.518 | 30.521 | 2.037 | 69.036 | 1.248 |
| Shareholders Funds | - | 316 | 795 | 1.917 | 56.187 | 81.787 | 115.116 | 117.632 | 177.510 | 121.540 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 147 | 3.724 | 3.616 | 4.724 | 4.323 | 35.925 | 4.679 | 2.049 | 45.212 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Bellegynecologie Srl